Korro Bio, Inc. Common Stock (KRRO) is a publicly traded Healthcare sector company. As of November 18, 2026, KRRO trades at $12.37 with a market cap of $174.45M and a P/E ratio of -0.97. KRRO moved -3.07% today. Year to date, KRRO is +54.60%; over the trailing twelve months it is +101.11%. Its 52-week range spans $5.20 to $55.89. Analyst consensus is strong buy with an average price target of $19.83. Rallies surfaces KRRO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for KRRO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $12.37 |
| Market Cap | $174.45M |
| P/E Ratio | -0.97 |
| EPS | $-10.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.89 |
| 52-Week Low | $5.20 |
| Volume | 146.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.38M |
| Net Income | $-106.64M |
| Gross Margin | 0.00% |
6 analysts cover KRRO: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.83.